目的:探讨不同时机宫腔镜检查对反复胚胎移植未孕患者后续体外受精-胚胎移植(IVF-ET)临床妊娠结局的影响。方法:回顾性分析2025年1月至2025年10月于东莞康华医院生殖医学科就诊的206例行IVF-ET助孕研究对象的临床资料。根据宫腔镜检查时机分为三组:A组(胚胎移植前检查,n=82)、B组(胚胎移植1次失败后检查,n=70)、C组(胚胎移植2次失败后检查,n=54)。比较三组研究对象后续IVF-ET周期的临床妊娠率。结果:三组研究对象基线年龄、不孕年限、BMI、AMH等指标差异无统计学意义(P>0.05)。总人群临床妊娠率为53.59%(97/206),其中A组妊娠率为72.0%(59/82),B组为35.7%(25/70),C组为24.1%(13/54),组间差异有统计学意义(P<0.001)。免疫双染阳性研究对象占86.27%(176/206),其在组间分布均衡,未改变主要结论。结论:对于IVF-ET助孕研究对象,胚胎移植前进行宫腔镜检查并处理异常,可能与后续临床妊娠率升高相关;延迟至1次或2次胚胎移植失败后再检查,妊娠获益可能大幅降低。提示胚胎移植前常规行宫腔镜评估的必要性。
Objective: To investigate the impact of different timing of hysteroscopy on the subsequent clinical pregnancy outcomes of patients with recurrent embryo transfer failure undergoing in vitro fertilization - embryo transfer (IVF-ET). Methods: The clinical data of 206 patients who underwent IVF-ET assisted pregnancy treatment at the Reproductive Medicine Department of Dongguan Kanghua Hospital from January 2025 to October 2025 were retrospectively analyzed. The patients were divided into three groups based on the timing of hysteroscopy: Group A (examined before embryo transfer, n = 82), Group B (examined after one failed embryo transfer, n = 70), and Group C (examined after two failed embryo transfers, n = 54). The clinical pregnancy rates of the subsequent IVF-ET cycles of the three groups were compared. Results: There were no statistically significant differences in baseline age, duration of infertility, BMI, AMH, etc. among the three groups (P > 0.05). The overall clinical pregnancy rate of the population was 53.59% (97/206), with the pregnancy rates in Group A being 72.0% (59/82), in Group B 35.7% (25/70), and in Group C 24.1% (13/54). The differences among the groups were statistically significant (P < 0.001). Immunobright staining positive study subjects accounted for 86.27% (176/206), and their distribution among the groups was balanced, without changing the main conclusion. Conclusion: For patients undergoing IVF-ET assisted pregnancy treatment, performing hysteroscopy and treating abnormalities before embryo transfer may be associated with an increased subsequent clinical pregnancy rate; delaying the examination until one or two failed embryo transfers may significantly reduce the pregnancy benefit. It suggests the necessity of routine hysteroscopy assessment before embryo transfer.
目的 探讨精子DNA碎片指数(DFI)对体外受精-胚胎移植(IVF-ET)胚胎发育及妊娠结局的影响,为优化男性生育力评估及辅助生殖治疗策略提供依据。方法 回顾性分析2023年1月—2024年1月于徐州市妇幼保健院接受IVF-ET治疗的126对不孕夫妇,根据男方DFI检测结果分为低碎片组(DFI≤15%,n=42)、临界组(15%<DFI<30%,n=45)和高碎片组(DFI≥30%,n=39)。比较三组患者受精相关指标、胚胎发育指标及妊娠结局指标的差异,并分析DFI与各指标的相关性。结果 低碎片组双原核率(2PN)率、优质胚胎率及囊胚形成率均高于临界组和高碎片组(P<0.001),低碎片组1PN率、多PN率均低于临界组和高碎片组(P<0.001);三组种植率、临床妊娠率、早期流产率比较差异无统计学意义(P>0.05),但高碎片组活产率低于低碎片组(P<0.05)。相关性分析结果表明,DFI与优质胚胎率(r=-0.412,P<0.001)、囊胚形成率(r=-0.387,P<0.001)、活产率(r=-0.287,P=0.012)呈负相关,与早期流产率(r=0.206,P=0.059)、种植率(r=-0.215,P=0.058)、临床妊娠率(r=-0.203,P=0.072)无显著相关性。结论 精子DNA碎片指数是影响IVF-ET胚胎发育及妊娠结局的重要因素,高DFI主要通过降低胚胎发育潜能及增加流产风险导致活产率下降,临床需对高DFI患者进行干预以改善治疗结局。
Objective To investigate the impact of sperm DNA fragmentation index(DFI)on embryo development and pregnancy outcomes of in vitro fertilization-embryo transfer(IVF-ET),and to provide a basis for optimizing male fertility assessment and assisted reproductive treatment strategies.Methods A retrospective analysis was performed on 126 infertile couples undergoing IVF-ET treatment at the Reproductive Medicine Center of Xuzhou Maternal and Child Health Hospital from January 2023 to January 2024.According to the male DFI test results,they were divided into three groups:low fragmentation group(DFI≤15%,n=42),critical group(15% < DFI < 30%,n=45),and high fragmentation group(DFI≥30%,n=39).Differences in fertilization-related indicators,embryo development indicators,and pregnancy outcome indicators were compared among the three groups,and the correlation between DFI and each indicator was analyzed.Results The 2 pronuclei rate(PN)rate,high-quality embryo rate,and blastocyst formation rate in the low fragmentation group were significantly higher than those in the critical and high fragmentation groups(P<0.001).The 1PN rate and multi-PN rate in the low fragmentation group were significantly lower than those in the critical and high fragmentation groups(P<0.001).There was no significant difference in the three groups of implantation rate,clinical pregnancy rate and early abortion rate(P>0.05),but the live birth rate of high fragment group was significantly lower than that of low fragment group(P<0.05).The results of correlation analysis showed that DFI was significantly negatively correlated with the rate of high quality embryos(r=-0.412,P<0.001),blastocyst formation rate(r=-0.387,P<0.001)and live birth rate(r=-0.287,P=0.012),but not with the rate of early abortion(r=0.206,P=0.059),implantation rate(r=-0.215,P=0.058)and clinical pregnancy rate(r=-0.203,P=0.072).Conclusions Sperm DFI is an important factor affecting embryo development and pregnancy maintenance in IVF-ET.High DFI leads to a decrease in live birth rate mainly by reducing embryo developmental potential and increasing the risk of early abortion.Clinically,early intervention is needed for patients with high DFI to improve treatment outcomes.
目的 比较细胞因子TGF-β、IL-10、TNF-α、Th17在不同妊娠结局的妊娠期亚临床甲减孕妇血清中的差异,探索细胞因子在不同妊娠结局中的作用。方法 随机选择2018年1月—2018年12月在我院就诊的66例确诊为因妊娠期亚临床甲减而出现不良妊娠结局的孕妇与同期妊娠结局正常的66例孕妇进行病例对照研究,比较不同妊娠结局孕妇的血清TGF-β、IL-10、TNF-α、Th17的差异;结果 ① 亚临床甲减组的TPOAb、TgAb、TRAb阳性率高于正常妊娠组,同时TNF-α、Th17均高于正常妊娠组,而TGF-β、IL-10均低于正常妊娠组,差异有统计学意义(P<0.05)。② 因子分析发现:在TPOAb、TgAb、TRAb、TGF-β、IL-10、TNF-α、Th17七个影响妊娠期亚临床甲减不良妊娠结局的相关因素中,TGF-β、IL-10、TNF-α、Th17在第1影响因子,特征值达2.347;TPOAb、TgAb、TRAb是次要影响因子,特征值为1.162。结论 TGF-β、IL-10、TNF-α、Th17与妊娠期亚临床甲状腺功能减退症的不良妊娠结局有密切关系,TGF-β、IL-10、TNF-α、Th17是影响妊娠期亚临床甲减不良妊娠结局的主要因子;TPOAb、TgAb、TRAb是影响妊娠期亚临床甲减不良妊娠结局的次要因子。
Objective To compare the serum levels of TGF-β, IL-10, TNF-α and Th17 in pregnant women with subclinical hypothyroidism in different pregnancy outcomes. Methods A case-control study was conducted in 66 pregnant women with adverse pregnancy outcomes due to subclinical hypothyroidism during pregnancy and 66 pregnant women with normal pregnancy outcomes during the same period. The differences of serum TGF-β, IL-10, TNF-α and Th17 among pregnant women with different pregnancy outcomes were compared. Results ①The positive rates of TPOAb, TgAb and TRAb in subclinical hypothyroidism group were higher than those in normal pregnancy group, and TNF-α and Th17 were higher than those in normal pregnancy group, while TGF-βand IL-10 were lower than those in normal pregnancy group (P<0.05). ②Factor analysis found that TPOAb, TgAb, TRAb, TGF-β, IL-10, TNF-α and Th17 were the factors related to adverse pregnancy outcomes of subclinical hypothyroidism in pregnancy. TGF-β, IL-10, TNF-α and Th17 were the main influencing factors with a characteristic value of 2.347; TPOAb, TgAb and TRAb were the second influencing factors,with a characteristic value of 1.162. Conclusion ①TGF-β, IL-10, TNF-α, Th17 are closely related to the occurrence and pregnancy outcome of subclinical hypothyroidism in pregnancy. ②TGF-β, IL-10, TNF-α and Th17 are the main factors affecting the adverse pregnancy outcomes of subclinical hypothyroidism in pregnancy;TPOAb, TgAb and TRAb are the secondary factors affecting the adverse pregnancy outcomes of subclinical hypothyroidism in pregnancy,
目的 探讨孕期生殖道菌群变化特征及其与不良妊娠结局的相关性。方法 选取2015年1月—2015年9月期间在我院妇产科门诊进行常规产科检查的90例孕妇为研究对象,根据孕期分为孕早期组28例(孕周<14周),孕中期组29例(孕周14~28周),孕晚期组33例(29~42周)。采集阴道分泌物或宫颈分泌物,对生殖道菌群进行检测。比较三组生殖道菌群分布情况。根据细菌检测结果分为阳性组与阴性组,分别为44例、46例。观察两组不良妊娠结局发生情况,分析生殖道菌群变化特征及其与不良妊娠结局的相关性。结果 90例孕妇中,细菌检测阳性44例,占48.89%,依次为解脲脲原体20例(45.45%)、假丝酵母菌属9例(20.45%)、肠杆菌属8例(18.18%)、葡萄球菌属3例(6.82%)、阴道加德纳菌属2例(4.55%)与衣原体2例(4.55%);孕早期、孕中期、孕晚期孕妇生殖道菌群分布情况相比,差异无统计学意义(P>0.05);细菌检测阳性者胎膜早破、产褥感染、新生儿感染、早产发生率高于细菌检测阴性者,差异有统计学意义(P<0.05);不同菌属类型者不良妊娠结局相比,差异无统计学意义(P>0.05)。结论 孕期生殖道菌群以解脲脲原体、假丝酵母菌属、肠杆菌属为主,细菌检测阳性者不良妊娠结局发生率高,而不同菌属类型与不良妊娠结局无关。
Objective To investigate the correlation between change characteristics of pregnant genital tract flora and adverse pregnancy outcomes. Methods 90 pregnant women received routine obstetric examination in our obstetrics and gynecology of hospital from January 2015 to September 2015 were selected as research object. According to duration of pregnancy, they were divided into 28 cases of early pregnancy group (gestational weeks<14 weeks), 29 cases of middle pregnancy group (14~28 weeks) and 33 cases of late pregnancy group (29~42 weeks). The vaginal or cervical secretions were collected, and genital tract flora was detected. The genital tract flora distribution of three groups were compared. According to bacteria detection results, patients were divided into 44 cases of positive group and 46 cases of negative group. The adverse pregnancy outcomes of two groups were observed, and the correlation between change characteristics of pregnant genital tract flora and adverse pregnancy outcomes was analyzed. Results Among 90 pregnant women, there were 44 cases of positive bacteria (48.89%), which included 20 cases of ureaplasma urealyticum(45.45%), 9 cases of Candida (20.45%), 8 cases of enterobacter (18.18%), 3 cases of staphylococcus (6.82%), 2 cases of vaginal gardnerella (4.55%) and 2 cases of chlamydia (4.55%); There was no statistical difference in the genital tract flora distribution among early, middle, late pregnancy group (P>0.05); The incidence of premature rupture of membrane, puerperal infection, neonatal infection and premature birth in patients with positive bacteria was higher than that in patients with negative bacteria (P<0.05); There was no statistical difference in the adverse pregnancy outcomes in patients with different types of bacterial genus (P>0.05). Conclusion Pregnant genital tract flora are mainly ureaplasma urealyticum, candida and enterobacter, and the incidence of adverse pregnancy outcomes in patients with positive bacteria is higher, but different types of bacterial genus has no correlation with adverse pregnancy outcomes.
目的 探讨宫腔积血对于中晚期妊娠结局的影响以及影响的因素。方法 结合477例中晚期宫腔积血孕妇的临床资料分析,根据妊娠结局分为正常妊娠结局组(NP)及不良妊娠结局组(AP)。结果 AP的平均孕周(23.22±6.87周)明显大于NP(16.11±4.76周),两组有明显差异性(P<0.001)。两组首次B超宫腔积血平均体积分别为8.01(2.22~28.67)(NP),13.05(3.54~26.34)mL(AP)(P=0.001),但相邻第二次测量结果两组相差不大(P=0.230)。AP组中胎盘下血肿的比率(53.4%)明显大于NP组(24.2%),而绒毛膜下血肿比率(44.0%)明显小于NP(73.8%),两组有明显差异性(P<0.001)。宫缩也是影响因素之一,在AP组可扪及宫缩的病例(88例55.3%)明显高于NP(38例11.9%),两组有明显差异性(P<0.001)。但在阴道流血率方面两组没有明显差异(P=0.407)。结论 妊娠中晚期宫腔积血可能会导致不良妊娠结局,而首次出现的孕周,急性大量宫腔出血、宫腔积血位置以及是否伴有宫缩都是影响妊娠结局的重要因素。
Objective To study the poor pregnancy outcomes of patients with intrauterine hematoma in the second and third trimesters, and discuss the risk factors. Methods We analyzed the clinical data of 477 patients who underwent routine examination in our hospital from January 2010 to June 2016 and classified them into normal pregnancy (NP) group and adverse pregnancy (AP) group according to their pregnancy outcomes. Results Gestational age at first detection of hematoma of AP group(23.22±6.87 weeks) was more than NP group (16.11±4.76 weeks)(P<0.001). The volumes of hematoma during the first detection were significantly different between the two groups (P=0.001).The average hematoma volume were 8.01(2.22-28.67)(NP),13.05(3.54-26.34)mL(AP)respectively. However, the hematoma volumes recorded in the second B-ultrasound examination were not significantly different between the two groups (P=0.230). In the AP group, the incidence of retroplacental hematoma (53.4%) was significantly higher than in the NP group (24.2%), while the incidence of subchorionic hematoma (44.0%) was significantly lower than in the NP group (73.8%)(P<0.001). The incidence of palpable contractions in the AP group (62.8%) was significantly higher than in the NP group (12.1%), P<0.001. However, the incidence of vaginal bleeding was similar (P=0.407). Conclusion Intrauterine hematoma in the second and third trimester may lead to adverse pregnancy outcomes. Risk factors for poor pregnancy outcomes are included gestational age at first diagnosis, acute and large intrauterine bleeding, location of hematoma and accompanying contraction.
目的 探讨高龄妊娠期糖尿病(GDM)产妇糖耐量的特点及其与妊娠结局的关系。方法 选择2020年1月1日—2024年12月31日在广州市第一人民医院规律产检并分娩的高龄产妇727例,包括高龄初产妇226例(GDM 78例)和高龄经产妇501例(GDM 131例),按照75 g OGTT血糖异常项数进行分组:一项血糖异常产妇为GDM I组(高龄初产妇38例,高龄经产妇68例);两项血糖异常产妇为GDM Ⅱ组(高龄初产妇26例,高龄经产妇51例);三项血糖异常产妇为GDM Ⅲ组(高龄初产妇14例,高龄经产妇12例);75 g OGTT正常高龄产妇为对照组。收集研究对象一般资料、75g OGTT血糖及相关妊娠结局进行分析比较。结果 高龄初产妇GDM发生率(34.51%)较高龄经产妇GDM发生率(26.15%)高,差异具有统计学意义(P=0.021);高龄初产妇GDM Ⅲ型宫内感染(28.57%)、产后出血(14.29%)发生率最高,差异具有统计学意义(P=0.037、0.039);高龄初产妇GDM I型早产(23.68%)发生率最高,差异具有统计学意义(P=0.013)。高龄初产妇及经产妇GDM Ⅱ型的羊水过多、甲状腺功能减退、宫内感染、早产发生率均呈上升趋势。结论 高龄妊娠糖尿病产妇随OGTT血糖异常项增多出现不良妊娠结局风险升高,其中高龄初产妇的早产、宫内感染及产后出血的发生率更高,因此,针对高龄初产妇,应更加注重孕期血糖及健康管理,以减少不良妊娠结局的发生。
Objective To analyze glucose tolerance characteristics in elderly pregnant women with gestational diabetes mellitus(GDM)and relationship with pregnancy outcomes.Methods From January 1,2020,and December 31,2024,727 elderly pregnant women who underwent routine prenatal examinations and delivered in Guangzhou First People’s Hospital were recruit.Among them,226 were elderly primiparas and 501 were elderly multiparas.GDM was diagnosed in 78 elderly primiparas and 131 elderly multiparas.Based on the results of the 75 g oral glucose tolerance test(OGTT),GDM cases were classified as follows:GDM I(one abnormal glucose value;38 elderly primiparas,68 elderly multiparas),GDM II(two abnormal values;26 elderly primiparas,51 elderly multiparas),and GDM Ⅲ(three abnormal values;14 elderly primiparas,12 elderly multiparas).Elderly pregnant women with normal OGTT results served as the control group.General clinical data and pregnancy outcomes were collected.The prevalence and characteristics of GDM in elderly primiparas and multiparas were analyzed.Results The incidence of GDM was significantly higher in elderly primiparas than in elderly multiparas(P=0.021).The incidence of intrauterine infection and postpartum hemorrhage was highest in elderly primiparas with GDM Ⅲ(P=0.037,0.039).The incidence of preterm birth was highest in elderly primiparas with GDM I(P=0.013).The incidence of polyhydramnios,hypothyroidism,intrauterine infection,and preterm birth showed an increasing trend in both elderly primiparas and multiparas with GDM II.Conclusions Elderly primiparas with more severe glucose tolerance abnormalities are at a higher risk of adverse pregnancy outcomes.Enhanced blood glucose monitoring and comprehensive health management during pregnancy are crucial for reducing the incidence of adverse outcomes in this population.